Early diagnosis of esophageal adenocarcinoma.
The incidence of esophageal adenocarcinoma has increased dramatically in developed countries during the past 2 decades, and prognosis remains very poor. Gastroesophageal reflux disease is an important risk factor for this cancer that develops in patients with specialized esophageal metaplasia (Barrett's esophagus). Careful periodic endoscopic examinations, with random biopsy sampling of the entire mucosal surface, are usually recommended for the surveillance of these patients. Several innovative techniques have recently been developed to improve the accuracy of diagnosis of intestinal metaplasia, dysplasia, and early adenocarcinoma in Barrett's esophagus. Some of these techniques (eg, chromoendoscopy, magnifying endoscopy, and light-induced fluorescence endoscopy) are intended to identify suspicious areas of the mucosa not visible during conventional endoscopic examination and to perform targeted biopsies toward these areas to avoid sampling errors. Optical coherence tomography and confocal laser scanning microscopy are other powerful techniques that provide real-time cross-sectional tissue images at a resolution close to that of histology. They allow tissue characterization based solely on optical properties and are likely to replace excisional biopsies. Although promising, none of these techniques is currently recommendable for routine surveillance of patients with Barrett's esophagus. Further evaluation is warranted to define the optimal method and standardize the procedures.
Buecher
Bruno
B
CIC Inserm and Department of Gastroenterology, and Hepatology, CHU Hôtel-Dieu, Nantes Cedex, France.
Galmiche
Jean Paul
JP
D000230:Adenocarcinoma / Q000175:diagnosis*; D019937:Diagnostic Techniques and Procedures; D004938:Esophageal Neoplasms / Q000175:diagnosis*; D006801:Humans; D015994:Incidence; D008207:Lymphatic Metastasis; D011379:Prognosis; D013997:Time Factors; D014481:United States / Q000453:epidemiology